Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
5 Reasons To Buy Eli Lilly
05:27pm, Monday, 21'st Apr 2025
Eli Lilly's stock price rise of 9% YTD might not look like a lot on its own, but in the context of the recent market decline, it's still a standout performance. With no end in sight for market uncerta
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:05am, Monday, 21'st Apr 2025
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study
09:40am, Monday, 21'st Apr 2025
Eli Lilly's stock surges as its investigational oral GLP-1 pill, orforglipron, achieves the primary and key secondary goals in the first late-stage study for adults with T2D.
Healthcare ETFs Tug of War: Insurers Tumble, Pharma Surges
09:30am, Monday, 21'st Apr 2025
Healthcare ETFs split as insurers stumble and pharma surges -- highlighting the necessity of smart industry picks.
Strength Seen in Lilly (LLY): Can Its 14.3% Jump Turn into More Strength?
09:20am, Monday, 21'st Apr 2025
Lilly (LLY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down
LLY, NVO and AMGN Forecast – Pharma Stocks to Open Mixed
09:00am, Monday, 21'st Apr 2025
The three pharma stocks in this analysis all look a bit mixed in the premarket, after seeing some momentum late last week. This is especially true with LLY, as you will see on the charts.
Did Eli Lilly Just Say Checkmate to Novo Nordisk?
04:30am, Monday, 21'st Apr 2025
Novo Nordisk (NVO -7.78%) has seen revenue soar in recent years thanks to two drugs that have helped people around the world lose weight. The molecule is semaglutide, and it's sold under the name Ozem
Eli Lilly: A New Leader In Weight Loss Drugs Is Clearly Emerging
09:00am, Sunday, 20'th Apr 2025
Eli Lilly's recent Phase III results for its oral weight loss pill have demonstrated remarkable results. LLY has emerged as the frontrunner to tap into the next stage of growth through Orforglipron, p
Prediction: Eli Lilly's Newest GLP-1 Drug Will Be a Game-Changer for the Stock
06:20am, Sunday, 20'th Apr 2025
Drugmaker Eli Lilly (LLY 14.56%) hasn't been exempt from the recent market pullback, but its stock shot higher following the announcement that its newest GLP-1 drug had successfully completed the firs
Is Eli Lilly Stock a Buy Right Now?
04:05pm, Saturday, 19'th Apr 2025
One of the more interesting aspects about President Donald Trump's recent tariffs is that each major industry has shown at least some degree of weakness, regardless of whether the policies have direct
Eli Lilly's Experimental Weight Loss Pill Succeeded in Its First Pivotal Trial. Is It Time to Buy?
03:23am, Saturday, 19'th Apr 2025
More than 2 out of 5 American adults are obese, according to the Centers for Disease Control. With this figure in mind, it's no wonder Wall Street investment banks are telling anyone who will listen t
The Score: UnitedHealth, Netflix, Eli Lilly and More Stocks That Defined the Week
05:02pm, Friday, 18'th Apr 2025
Here are some of the major companies whose stocks moved on the week's news
Eli Lilly Vows to Make Weight-Loss Pill in U.S. as Trump Pushes for Domestic Manufacturing
11:46am, Friday, 18'th Apr 2025
Eli Lilly plans to make its experimental drug orforglipron in the U.S. after it secures regulatory approval, says CEO Dave Ricks.
S&P 500 (NYSEARCA: SPY) Live: DLTR (Nasdaq: DLTR), FIS (NYSE: FIS) Rise Despite Hawkish Tone
10:31am, Friday, 18'th Apr 2025
Live Updates Live Coverage Has Ended S&P Holds Grip 1:39 pm by Gerelyn Terzo The broader market is moving slightly higher, with the S&P 500 holding onto modest gains while the Dow Jones Indust
Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (April 2025)
07:50am, Friday, 18'th Apr 2025
From late 2020 to the summer of 2024, Eli Lilly & Co. (NYSE: LLY) stock was on a tear, up more than 635%.
